References

  1. CHOWN B et al. A "D-POSITIVE" MAN WHO PRODUCED ANTI-D. Vox Sang, 1963. [Citation] [RHeference]
  2. Lalezari P et al. Development of direct antiglobulin reaction accompanying alloimmunization in a patient with Rhd (D, category III) phenotype. Vox Sang, 1975. [Citation] [RHeference]
  3. Simsek S et al. Rapid Rh D genotyping by polymerase chain reaction-based amplification of DNA. Blood, 1995. [Citation] [RHeference]
  4. Beckers EA et al. The R0Har RH:33 phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RHD gene. Br J Haematol, 1996. [Citation] [RHeference]
  5. Faas BH et al. Involvement of Ser103 of the Rh polypeptides in G epitope formation. Transfusion, 1996. [Citation] [RHeference]
  6. Beckers EA et al. The genetic basis of a new partial D antigen: DDBT. Br J Haematol, 1996. [Citation] [RHeference]
  7. Beckers EA et al. Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype. Transfusion, 1996. [Citation] [RHeference]
  8. Faas BH et al. Molecular background of VS and weak C expression in blacks. Transfusion, 1997. [Citation] [RHeference]
  9. Gassner C et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion, 1997. [Citation] [RHeference]
  10. Maaskant-van Wijk PA et al. Evidence That the RHDVI Deletion Genotype Does Not Exist Blood, 1997. [Citation] [RHeference]
  11. Daniels GL et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion, 1998. [Citation] [RHeference]
  12. Wagner FF et al. Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood, 1998. [Citation] [RHeference]
  13. Maaskant-van Wijk PA et al. Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion, 1998. [Citation] [RHeference]
  14. Wagner FF et al. Molecular basis of weak D phenotypes. Blood, 1999. [Citation] [RHeference]
  15. Hemker MB et al. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood, 1999. [Citation] [RHeference]
  16. Müller TH et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion, 2001. [Citation] [RHeference]
  17. Faas BH et al. Partial expression of RHc on the RHD polypeptide. Transfusion, 2001. [Citation] [RHeference]
  18. M. J. Rodrigues et al. Identification of partial D antigen, DBT, with allo-anti-D in the serum Transfusion Medicine, 2002. — Abstract — [RHeference]
  19. Körmöczi GF et al. Molecular and serologic characterization of DWI, a novel "high-grade" partial D. Transfusion, 2004. [Citation] [RHeference]
  20. Körmöczi GF et al. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types. Transfusion, 2005. [Citation] [RHeference]
  21. Gassner C et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion, 2005. [Citation] [RHeference]
  22. Xu Q et al. Systemic analysis and zygosity determination of the RHD gene in a D-negative Chinese Han population reveals a novel D-negative RHD gene. Vox Sang, 2005. [Citation] [RHeference]
  23. Luettringhaus TA et al. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion, 2006. [Citation] [RHeference]
  24. Grootkerk-Tax MG et al. RHD(T201R, F223V) cluster analysis in five different ethnic groups and serologic characterization of a new Ethiopian variant DARE, the DIII type 6, and the RHD(F223V). Transfusion, 2006. [Citation] [RHeference]
  25. Fichou Y et al. Weak D caused by a founder deletion in the RHD gene. Transfusion, 2012. [Citation] [RHeference]
  26. Fichou Y et al. Variant screening of the RHD gene in a large cohort of subjects with D phenotype ambiguity: report of 17 novel rare alleles. Transfusion, 2012. [Citation] [RHeference]
  27. Goldman M et al. Identifying D-positive donors using a second automated testing platform. Immunohematology, 2013. [Citation] [RHeference]
  28. Fichou Y et al. A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes. Transfusion, 2013. [Citation] [RHeference]
  29. Chen JM et al. Small deletions within the RHD coding sequence: a report of two novel mutational events and a survey of the underlying pathophysiologic mechanisms. Transfusion, 2013. [Citation] [RHeference]
  30. Chou ST et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood, 2013. [Citation] [RHeference]
  31. Haer-Wigman L et al. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification. Transfusion, 2013. [Citation] [RHeference]
  32. Gassner C et al. Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76. Transfusion, 2013. [Citation] [RHeference]
  33. Fichou Y et al. Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles. Transfusion, 2013. [Citation] [RHeference]
  34. C M Westhoff et al. A Weak D Phenotype Discovered in Nine Patients in Western Canada due to a Nucleotide 1187C>G (Pro396Arg) Change in RHD Transfusion, 2014. — Abstract — [RHeference]
  35. Xhetani M et al. Distribution of Rhesus blood group antigens and weak D alleles in the population of Albania. Blood Transfus, 2014. [Citation] [RHeference]
  36. Fichou Y et al. Extensive functional analyses of RHD splice site variants: Insights into the potential role of splicing in the physiology of Rh. Transfusion, 2015. [Citation] [RHeference]
  37. Yang HS et al. Primary anti-D alloimmunization induced by "Asian type" RHD (c.1227G>A) DEL red cell transfusion. Ann Lab Med, 2015. [Citation] [RHeference]
  38. Ipe TS et al. Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease. J Pediatr Hematol Oncol, 2015. [Citation] [RHeference]
  39. Garcia F et al. New RHD variant alleles. Transfusion, 2015. [Citation] [RHeference]
  40. Berardi P et al. Weak D type 67 in four related Canadian blood donors. Immunohematology, 2015. [Citation] [RHeference]
  41. Flesch BK et al. A serologic weakly reactive RhD is caused by a RHD 374T>A (Ile125Asn). Transfusion, 2015. [Citation] [RHeference]
  42. Seo MH et al. An effective diagnostic strategy for accurate detection of RhD variants including Asian DEL type in apparently RhD-negative blood donors in Korea. Vox Sang, 2016. [Citation] [RHeference]
  43. Vege S et al. D typing discrepancies and anti-D production associated with six new RHD alleles. Transfusion, 2016. — Abstract — [RHeference]
  44. Goldman M et al. Identification of six new RHCE variant alleles in individuals of diverse racial origin. Transfusion, 2016. [Citation] [RHeference]
  45. Lopez GH et al. A D+ blood donor with a novel RHD*D-CE(5-6)-D gene variant exhibits the low-frequency antigen RH23 (D(W) ) characteristic of the partial DVa phenotype. Transfusion, 2016. [Citation] [RHeference]
  46. Clarke G et al. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients. Transfusion, 2016. [Citation] [RHeference]
  47. C Nixon et al. A Patient with Weak D Type 3 and Anti-D Alloimmunization Transfusion, 2016. — Abstract — [RHeference]
  48. Stegmann TC et al. Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women. Br J Haematol, 2016. [Citation] [RHeference]
  49. Raud L et al. From genetic variability to phenotypic expression of blood group systems. Transfus Clin Biol, 2017. [Citation] [RHeference]
  50. Hyland CA et al. Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types. Pathology, 2017. [Citation] [RHeference]
  51. Fennell K et al. Effect on gene expression of three allelic variants in GATA motifs of ABO, RHD, and RHCE regulatory elements. Transfusion, 2017. [Citation] [RHeference]
  52. Chou ST et al. Application of genomics for transfusion therapy in sickle cell anemia. Blood Cells Mol Dis, 2017. [Citation] [RHeference]
  53. Ji YL et al. RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay. Vox Sang, 2017. [Citation] [RHeference]
  54. Lopez GH et al. Genotyping by sequencing defines independent novel RHD variants for an antenatal patient and a blood donor. Transfusion, 2017. [Citation] [RHeference]
  55. Chou ST et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv, 2017. [Citation] [RHeference]
  56. Kim B et al. Application of Multiplex Ligation-Dependent Probe Amplification Assay for Genotyping Major Blood Group Systems Including DEL Variants in the D-Negative Korean Population. Ann Lab Med, 2018. [Citation] [RHeference]
  57. Kulkarni SS et al. RHD-Positive Alleles among D- C/E+ Individuals from India. Transfus Med Hemother, 2018. [Citation] [RHeference]
  58. Turley E et al. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31). Transfusion, 2018. [Citation] [RHeference]
  59. Chun S et al. The synonymous nucleotide substitution RHD 1056C>G alters mRNA splicing associated with serologically weak D phenotype. J Clin Lab Anal, 2018. [Citation] [RHeference]
  60. Lopez GH et al. A DEL phenotype attributed to RHD Exon 9 sequence deletion: slipped-strand mispairing and blood group polymorphisms. Transfusion, 2018. [Citation] [RHeference]
  61. Schoeman EM et al. Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory setting. Transfusion, 2018. [Citation] [RHeference]
  62. Fichou Y et al. Molecular basis of weak D expression in the Indian population and report of a novel, predominant variant RHD allele. Transfusion, 2018. [Citation] [RHeference]
  63. L Castilho et al. From genotyping to the functional and clinical interpretation of variations in blood group genes by 3D-protein structure investigation: two novel variant alleles in the RHD gene Vox Sanguinis, 2019. — Abstract — [RHeference]
  64. GA Denomme et al. A novel weak D 4.0-related allele and RHCE*ceCF defines a new rh haplotype in an autologous donor with an antibody to a high frequency antigen Vox Sanguinis, 2019. — Abstract — [RHeference]
  65. M Pisacka et al. Strong pregnancy induced anti-D immunization in del phenotype with RHD*01EL.04 allele Vox Sanguinis, 2019. — Abstract — [RHeference]
  66. Izaskun Apraiz et al. Performance Evaluation Study of ID RHD XT as a Molecular Tool for RHD Gene Screening in Pooled Blood Samples of Serologically D− C/E+ Donors Transfusion, 2019. — Abstract — [RHeference]
  67. Matzhold EM et al. RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expression. Transfusion, 2019. [Citation] [RHeference]
  68. Raud L et al. Weak D type 1, 2 and 3 subtype alleles are rare in the Western French population. Transfus Med, 2019. [Citation] [RHeference]
  69. Westhoff CM et al. Experience with RHD*weak D type 4.0 in the USA. Blood Transfus, 2019. [Citation] [RHeference]
  70. Schoeman EM et al. Comprehensive blood group antigen profile predictions for Western Desert Indigenous Australians from whole exome sequence data. Transfusion, 2019. [Citation] [RHeference]
  71. El Housse H et al. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors. Blood Transfus, 2019. [Citation] [RHeference]
  72. Stef M et al. RH genotyping by nonspecific quantitative next-generation sequencing. Transfusion, 2020. [Citation] [RHeference]
  73. Chun S et al. A new RHD variant allele (RHD Gly339Val) shows weakened D expression compared to RHD Gly339Glu and Gly339Arg mutants. Transfusion, 2020. [Citation] [RHeference]
  74. Thongbut J et al. Comprehensive Molecular Analysis of Serologically D-Negative and Weak/Partial D Phenotype in Thai Blood Donors. Transfus Med Hemother, 2020. [Citation] [RHeference]
  75. Matteocci A et al. Two new RHD alleles with deletions spanning multiple exons. Transfusion, 2021. [Citation] [RHeference]